1. Oxman AD, Cook DJ, Guyatt GH (1994) Users’ guides to the medical literature. VI. How to use an overview. Evidence-Based Medicine Working Group. JAMA 272: 1367-1371.

2. Swingler GH, Volmink J, Ioannidis JP (2003) Number of published systematic reviews and global burden of disease: Database analysis. BMJ 327: 1083-1084.

3. Canadian Institutes of Health Research (2006) Randomized controlled trials registration/application checklist (12/2006). Available: http://www.cihr-irsc.gc.ca/e/documents/rct_reg_e.pdf. Accessed 19 May 2009

4. Young C, Horton R (2005) Putting clinical trials into context. Lancet 366: 107.

5. Mulrow CD (1987) The medical review article: State of the science. Ann Intern Med 106: 485-488.

6. Sacks HS, Berrier J, Reitman D, Ancona-Berk VA, Chalmers TC (1987) Meta-analysis of randomized controlled trials. New Engl J Med 316: 450-455.

7. Sacks HS, Reitman D, Pagano D, Kupelnick B (1996) Meta-analysis: An update. Mt Sinai J Med 63: 216-224.

8. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, et al. for the QUOROM group (1999) Improving the quality of reporting of meta-analysis of randomized controlled trials: The QUOROM statement. Lancet 354: 1896-1900.

9. Green S, Higgins J, editors (2005) Glossary. Cochrane handbook for systematic reviews of interventions 4.2.5. The Cochrane Collaboration. Available: http://www.cochrane.org/resources/glossary.htm. Accessed 19 May 2009.

10. Strech D, Tilburt J (2008) Value judgments in the analysis and synthesis of evidence. J Clin Epidemiol 61: 521-524.

11. Moher D, Tsertsvadze A (2006) Systematic reviews: When is an update an update? Lancet 367: 881-883.

12. University of York (2009) Centre for Reviews and Dissemination. Available: http://www.york.ac.uk/inst/crd/. Accessed 19 May 2009.

13. The Joanna Briggs Institute (2008) Protocols & work in progress. Available: http://www.joannabriggs.edu.au/pubs/systematic_reviews_prot.php. Accessed 19 May 2009.

14. De Angelis C, Drazan JM, Frizelle FA, Haug C, Hoey J, et al. for the International Committee Medical Journal Editors (2004) Clinical trial registration: A statement from the International Committee of Medical Journal Editors. CMAJ 171: 606-607.

15. Whittington CJ, Kendall T, Fonagy P, Cottrell D, Cotgrove A, et al. (2004) Selective serotonin reuptake inhibitors in childhood depression: Systematic review of published versus unpublished data. Lancet 363: 1341-1345.

16. Bagshaw SM, McAlister FA, Manns BJ, Ghali WA (2006) Acetylcysteine in the prevention of contrast-induced nephropathy: A case study of the pitfalls in the evolution of evidence. Arch Intern Med 166: 161-166.

17. Biondi-Zoccai GG, Lotrionte M, Abbate A, Testa L, Remigi E, et al. (2006) Compliance with QUOROM and quality of reporting of overlapping meta-analyses on the role of acetylcysteine in the prevention of contrast associated nephropathy: Case study. BMJ 332: 202-209.

18. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche P, et al. and the PRISMA Group (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. PLoS Med 6: e1000100. doi:10.1371/journal.pmed.1000100

19. Altman DG, Schulz KR, Moher D, Egger M, Davidoff F, et al. for the CONSORT group (2001) The revised CONSORT statement for reporting randomized trials: Explanation and elaboration. Ann Intern Med 134: 663-694.

20. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, et al. for the STARD group (2003) Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD explanation and elaboration. Ann Intern Med 138: W1-W12.

21. Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, et al. for the STROBE initiative (2007) Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration. Ann Intern Med 147: W163-W194.

22. Moher D, Tetzlaff J, Tricco AC, Sampson M, Altman DG (2007) Epidemiology and reporting characteristics of systematic reviews. PLoS Med 4: e78. doi:10.1371/journal.pmed.0040078

23. Bhandari M, Morrow F, Kulkarni AV, Tornetta P (2001) Meta-analyses in orthopaedic surgery: A systematic review of their methodologies. J Bone Joint Surg Am 83-A: 15-24.

24. Kelly KD, Travers A, Dorgan M, Slater L, Rowe BH (2001) Evaluating the quality of systematic reviews in the emergency medicine literature. Ann Emerg Med 38: 518-526.

25. Richards D (2004) The quality of systematic reviews in dentistry. Evid Based Dent 5: 17.

26. Choi PT, Halpern SH, Malik N, Jadad AR, Tramer MR, et al. (2001) Examining the evidence in anesthesia literature: A critical appraisal of systematic reviews. Anesth Analg 92: 700-709.

27. Delaney A, Bagshaw SM, Ferland A, Manns B, Laupland KB (2005) A systematic evaluation of the quality of meta-analyses in the critical care literature. Crit Care 9: R575-R582.

28. Dickersin K (2005) Publication bias: Recognizing the problem, understanding its origins and scope, and preventing harm. In: Rothstein HR, Sutton AJ, Borenstein M, editors. Publication bias in meta-analysis—Prevention, assessment and adjustments. Chichester (UK): John Wiley & Sons. pp.11-33.

29. Sutton AJ (2005) Evidence concerning the consequences of publication and related biases. In: Rothstein HR, Sutton AJ, Borenstein M, editors. Publication bias in meta-analysis—Prevention, assessment and adjustments. Chichester (UK): John Wiley & Sons. pp. 175-192.

30. Lau J, Ioannidis JP, Terrin N, Schmid CH, Olkin I (2006) The case of the misleading funnel plot. BMJ 333: 597-600.

31. Ladabaum U, Chopra CL, Huang G, Scheiman JM, Chernew ME, et al. (2001) Aspirin as an adjunct to screening for prevention of sporadic colorectal cancer: A cost-effectiveness analysis. Ann Intern Med 135: 769-781.

32. Deeks JJ (2001) Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests. BMJ 323: 157-162.

33. Altman DG (2001) Systematic reviews of evaluations of prognostic variables. BMJ 323: 224-228.

34. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG (2001) Replication validity of genetic association studies. Nat Genet 29: 306-309.

35. Lavis J, Davies H, Oxman A, Denis J, Golden-Biddle K, et al. (2005) Towards systematic reviews that inform health care management and policy-making. J Health Serv Res Policy 10: 35-48.

36. Stewart LA, Clarke MJ (1995) Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working Group. Stat Med 14: 2057-2079.

37. Moja LP, Telaro E, D’Amico R, Moschetti I, Coe L, et al. (2005) Assessment of methodological quality of primary studies by systematic reviews: Results of the metaquality cross sectional study. BMJ 330: 1053-1055.

38. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, et al. for the GRADE Working Group (2008) GRADE: An emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336: 924-926.

39. Schunemann HJ, Jaeschke R, Cook DJ, Bria WF, El-Solh AA, et al. for the ATS Documents Development and Implementation Committee (2006) An official ATS statement: Grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med 174: 605-614.

40. Chan AW, Hrobjartsson A, Haahr MT, Gøtzsche PC, Altman DG (2004) Empirical evidence for selective reporting of outcomes in randomized trials: Comparison of protocols to published articles. JAMA 291: 2457-2465.

41. Chan AW, Krleza-Jeric K, Schmid I, Altman DG (2004) Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research. CMAJ 171: 735-740.

42. Silagy CA, Middleton P, Hopewell S (2002) Publishing protocols of systematic reviews: Comparing what was done to what was planned. JAMA 287: 2831-2834.